Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

Go back to Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
(NASDAQ: TLRY) Delayed: 2.94 +0.02 (0.68%)
Previous Close $2.92    52 Week High $ 
Open $2.90    52 Week Low $ 
Day High $3.00    P/E N/A 
Day Low $2.87    EPS $ 
Volume 2,227,745